The Supreme Court on Wednesday issued notices to the Centre, the States, the Union Territories and the Drugs Controller of India on a public interest writ petition seeking a direction for the promotion of generic drugs instead of branded ones by medical practitioners.
In the PIL filed before a Bench of Justices Dipak Misra and V. Gopala Gowda, advocate Reepak Kansal sought the court’s intervention to end flagrant violations and abuse of health norms due to the non-enforcement and non-implementation of norms/prohibitions, established under the Drugs and Cosmetics Act, 1940, and against non-implementation of the recommendations mentioned in the sixth Five-Year Plan.
